Drugs discovery firm strikes £360m licensing deal with pharmaceutical giant Sanofi

Manchester drug discovery group C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi, the French pharmaceutical giant, worth up to £360m. Under the license, Sanofi will develop and commercialise an oral therapy for the treatment of inflammatory diseases, ‘a multi-billion dollar market.’ Manchester drug discovery group C4X Discovery Read more…

Work begins on new £21m, 91,000 sq ft specialist workplace for science and technology businesses in Manchester

The £21m, 91,000 sq ft redevelopment of Base at Manchester Science Park is now underway; marking another significant milestone in the evolution of the masterplan for the Park, as the city’s Oxford Road Corridor innovation district takes another step forward. The development signifies a key chapter in Manchester’s economic recovery Read more…

Brain implant firm wins £12m funding with Graphene@Manchester nanotech

A collaboration between two Barcelona institutions and the Nanomedicine Lab at The University of Manchester – aimed at treating brain disorders such as epilepsy and Parkinson’s Disease – has secured £12m in funding, one of the largest investments to date in the European medical nanotechnology industry. INBRAIN Neuroelectronics is a spin-out company from the Read more…

​​​​​​​New gene therapy innovation centre to advance scientific discoveries into life-changing treatments

A pioneering gene therapy innovation centre at the University of Sheffield is set to advance scientific discoveries into promising treatment options for millions of patients with life-threatening diseases. A pioneering gene therapy innovation centre at the University of Sheffield is set to advance scientific discoveries into promising treatment options for Read more…

Nanotechnology could enable test for early Alzheimer’s Disease

University of Manchester scientists have discovered previously unseen blood biomarkers which could one day be used to test for Alzheimer’s disease, years before its symptoms appear. The ground-breaking study, published in ACS Nano, used cutting-edge nanotechnology uniquely developed and patented by the Nanomedicine Lab in Manchester, to extract blood signals of Read more…